Publication:
Real-life outcomes of Ocrelizumab treatment from 3 multiple sclerosis centers in Turkey

Simple item page
dc.contributor.authorsVural, E.; Terzi, M.; Sunter, G.; Gunal, D.; Agan, K.; Boz, C.
dc.date.accessioned2022-03-12T16:24:20Z
dc.date.accessioned2026-01-10T19:42:01Z
dc.date.available2022-03-12T16:24:20Z
dc.date.issued2019
dc.identifier.doidoiWOS:000485303103164
dc.identifier.eissn1477-0970
dc.identifier.issn1352-4585
dc.identifier.urihttps://hdl.handle.net/11424/226308
dc.identifier.wosWOS:000485303103164
dc.language.isoeng
dc.publisherSAGE PUBLICATIONS LTD
dc.relation.ispartofMULTIPLE SCLEROSIS JOURNAL
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleReal-life outcomes of Ocrelizumab treatment from 3 multiple sclerosis centers in Turkey
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.endPage751
oaire.citation.startPage751
oaire.citation.titleMULTIPLE SCLEROSIS JOURNAL
oaire.citation.volume25

Files

Collections

Araştırma Çıktıları